Table 1.
Age, Months | Doses | Bedouin Children | Jewish Children | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Total | PCV7-Type Carriage | +6PCV13-Type Carriage | NVT Carriage | No Carriage | Total | PCV-Type Carriage | +6PCV13-Type Carriage | NVT Carriage | No Carriage | ||
n = 3425 | n = 242 | n = 204 | n = 1190 | n = 1789 | n = 2503 | n = 92 | n = 92 | n = 796 | n = 1523 | ||
0–1 | 0 PCV7 | 307 | 13 | 15 | 72 | 207 | 116 | 1 | 2 | 12 | 101 |
≥1 PCV7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
0 + 6PCV13 | 307 | 13 | 15 | 72 | 207 | 116 | 1 | 2 | 12 | 101 | |
≥1 + 6PCV13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total for age | 307 | 13 | 15 | 72 | 207 | 116 | 1 | 2 | 12 | 101 | |
2–4 | 0 PCV7 | 167 | 11 | 12 | 63 | 81 | 56 | 2 | 2 | 12 | 40 |
1 PCV7 | 261 | 13 | 21 | 91 | 136 | 164 | 7 | 3 | 45 | 109 | |
2 PCV7 | 33 | 2 | 0 | 12 | 19 | 32 | 1 | 0 | 6 | 25 | |
0 + 6PCV13 | 208 | 18 | 16 | 75 | 99 | 87 | 7 | 3 | 18 | 59 | |
1 + 6PCV13 | 223 | 7 | 17 | 80 | 119 | 142 | 3 | 2 | 39 | 98 | |
2 + 6PCV13 | 30 | 1 | 0 | 11 | 18 | 23 | 0 | 0 | 6 | 17 | |
Total for age | 461 | 26 | 33 | 166 | 236 | 252 | 10 | 5 | 63 | 174 | |
5–12 | 0 PCV7 | 37 | 5 | 4 | 13 | 15 | 14 | 3 | 2 | 4 | 5 |
1 PCV7 | 165 | 22 | 18 | 56 | 69 | 38 | 3 | 3 | 17 | 15 | |
2 PCV7 | 761 | 58 | 44 | 267 | 392 | 545 | 16 | 12 | 160 | 357 | |
3 PCV7 | 32 | 2 | 3 | 14 | 13 | 26 | 0 | 2 | 3 | 21 | |
0 + 6PCV13 | 240 | 46 | 23 | 72 | 99 | 140 | 10 | 11 | 34 | 85 | |
1 + 6PCV13 | 133 | 16 | 14 | 47 | 56 | 44 | 1 | 2 | 18 | 23 | |
2 + 6PCV13 | 599 | 24 | 31 | 220 | 324 | 427 | 11 | 6 | 131 | 279 | |
3 + 6PCV13 | 23 | 1 | 1 | 11 | 10 | 12 | 0 | 0 | 1 | 11 | |
Total for age | 995 | 87 | 69 | 350 | 489 | 623 | 22 | 19 | 184 | 398 | |
13–24 | 0 PCV7 | 34 | 7 | 1 | 12 | 14 | 35 | 5 | 1 | 14 | 15 |
1 PCV7 | 41 | 5 | 4 | 10 | 22 | 20 | 1 | 2 | 6 | 11 | |
2 PCV7 | 164 | 25 | 13 | 59 | 67 | 132 | 4 | 12 | 40 | 76 | |
3 PCV7 | 517 | 16 | 27 | 190 | 284 | 469 | 13 | 12 | 192 | 252 | |
4 PCV7 | 19 | 0 | 1 | 8 | 10 | 27 | 1 | 0 | 8 | 18 | |
0 + 6PCV13 | 215 | 30 | 20 | 78 | 87 | 164 | 12 | 17 | 52 | 83 | |
1 + 6PCV13 | 66 | 3 | 6 | 23 | 34 | 49 | 1 | 4 | 18 | 26 | |
2 + 6PCV13 | 91 | 9 | 6 | 31 | 45 | 95 | 1 | 4 | 31 | 59 | |
3 + 6PCV13 | 393 | 11 | 14 | 141 | 227 | 364 | 10 | 2 | 157 | 195 | |
4 + 6PCV13 | 10 | 0 | 0 | 6 | 4 | 11 | 0 | 0 | 2 | 9 | |
Total for age | 775 | 53 | 46 | 279 | 397 | 683 | 24 | 27 | 260 | 372 | |
25–59 | 0 PCV7 | 220 | 32 | 17 | 64 | 107 | 191 | 22 | 19 | 41 | 109 |
1 PCV7 | 28 | 1 | 3 | 10 | 14 | 17 | 0 | 1 | 5 | 11 | |
2 PCV7 | 127 | 9 | 7 | 60 | 51 | 94 | 2 | 7 | 33 | 52 | |
3 PCV7 | 492 | 21 | 13 | 181 | 277 | 472 | 11 | 9 | 183 | 269 | |
4 PCV7 | 20 | 0 | 1 | 8 | 11 | 55 | 0 | 3 | 15 | 37 | |
0 + 6PCV13 | 420 | 45 | 34 | 138 | 203 | 384 | 25 | 28 | 106 | 225 | |
1 + 6PCV13 | 94 | 2 | 2 | 47 | 43 | 54 | 4 | 0 | 18 | 32 | |
2 + 6PCV13 | 39 | 1 | 0 | 16 | 22 | 44 | 2 | 1 | 18 | 23 | |
3 + 6PCV13 | 321 | 15 | 4 | 117 | 185 | 327 | 4 | 8 | 129 | 186 | |
4 + 6PCV13 | 13 | 0 | 1 | 5 | 7 | 20 | 0 | 2 | 6 | 12 | |
Total for age | 887 | 63 | 41 | 323 | 460 | 829 | 35 | 39 | 277 | 478 |
Data indicate the number of children enrolled who were not diagnosed with diseases potentially caused by pneumococcus, with complete data available, as detailed in Supplementary Table S1. We present the numbers of children receiving the specific dosing schedules assessed in Supplementary Table S3.
Abbreviations: +6PCV13, the 6 serotypes contained in PCV13 and not PCV7; PCV7, 7-valent pneumococcal conjugate vaccine; PCV13, 13-valent pneumococcal conjugate vaccine; NVT, nonvaccine type (serotypes not included in PCV13).